Praxis Precision Medicines
$57.519876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$57.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.31 (-3.86%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours
Why Robinhood?
You can buy or sell PRAX and other stocks, options, and ETFs commission-free!
About PRAX
Praxis Precision Medicines, Inc. Common Stock, also called Praxis Precision Medicines, is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA. The listed name for PRAX is Praxis Precision Medicines, Inc. Common Stock.
CEO
Marcio Souza
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
2.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
250.83K
High Today
$59.48
Low Today
$56.01
Open Price
$59.25
Volume
201.30K
52 Week High
$60.79
52 Week Low
$23.90
Collections
PRAX Earnings
-$12.10
-$8.07
-$4.03
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 5, Pre-Market